We’ll Now Return to Our Regularly-Scheduled Programming: Getting a Handle on 483 data

Feb. 23, 2007
That was the last of the entries from the old blog....and have to get back to work, now.   But before doing that, I'd like to let you know about an article that will be appearing in our next issue, analyzing FDA 483s and warning letters from the past few years. FDA makes this information publicly available on its Web site, but interpreting it correctly is very difficult, and recent articles in other journals (including those of our esteemed competitors) have not gotten the information right.  Michael Gregor of Compliance Gurus will be helping us with this, and you'll find the information on our web site, here and in print soon. -AMS
That was the last of the entries from the old blog....and have to get back to work, now.   But before doing that, I'd like to let you know about an article that will be appearing in our next issue, analyzing FDA 483s and warning letters from the past few years. FDA makes this information publicly available on its Web site, but interpreting it correctly is very difficult, and recent articles in other journals (including those of our esteemed competitors) have not gotten the information right.  Michael Gregor of Compliance Gurus will be helping us with this, and you'll find the information on our web site, here and in print soon. -AMS
About the Author

pharmamanufacturing | pharmamanufacturing